Rodolphe

Rodolphe Fischmeister，Director of Research INSERM.1981-1982: Post-doctoral Research Fellow， Department of Physiology & Biophysics， Dalhousie University， Halifax， Nova Scotia， Canada;1982-1983: Research Associate in Anatomy， Dept of Anatomy， Emory University， Atlanta， Georgia， USA;1983-1989: Research Associate INSERM， University Paris-Sud， Orsay， France;1989-1992: Director of Research INSERM， University Paris-Sud， Orsay， France;1992-1995: Director of Research INSERM， Head of Laboratory INSERM CJF 92-11， University Paris-Sud， Faculty of Pharmacy， Châtenay-Malabry， France;1998-2001: Head of Institute IFR75 – Signalisation et Innovation Thérapeutique， University Paris-Sud， Faculty of Pharmacy， Châtenay-Malabry， France;2003-2004: Visiting Professor， Department of Cell Biology， Emory University， Atlanta， Georgia， USA;1996-2005: Director of Research INSERM， Head of Laboratory INSERM U446， University Paris-Sud， Faculty of Pharmacy， Châtenay-Malabry， France;2006-: Director of Research INSERM， Head of Laboratory INSERM U769， University Paris-Sud， Faculty of Pharmacy， Châtenay-Malabry， France2006-2010: Head of Institute IFR141 - Innovation Thérapeutique: du Fondamental au Médicament， University Paris-Sud， Faculty of Pharmacy， Châtenay-Malabry， France2011-: Director of Research INSERM “Classe Exceptionnelle”;2011-: Head of the Laboratory of Excellence in Research on Medication and Innovative Therapeutics （LabEx LERMIT）.